Lauxera Growth I holds €100m first close

Alessia Argentieri
27 January 2021

Tweet
Facebook
LinkedIn
Google plus
Send to

Lauxera Capital Partners has held a first close on тЌ100m for its debut fund, Lauxera Growth I, dedicated to the European health technology industry.

The fund was launched six months ago with a target of €150m and a €200m hard-cap.

Lauxera is a newly created investment firm headquartered in Paris and dedicated to international investments across the healthcare sector.

The firm was founded in 2020 by partners Pierre Moustial, former CEO of Urgo and Fournier Pharma; Samuel Levy, physician and entrepreneur, founder of Allurion Technologies; and Alex Slack, an American healthcare investor, formerly at Maverick Capital and Jackson Square Partners.

"The Covid-19 crisis has highlighted the weaknesses of our healthcare systems," said co-founder Moustial. "Our goal is to disseminate innovations that improve the quality and robustness of healthcare delivery through health technology."

Lauxera's partners are located in Paris and San Francisco, to serve as a bridge between healthcare technologies founded in the EU to US customers and capital, with the aim of connecting portfolio companies with international markets.

"The US has the broadest and most mature investor base for healthtech growth companies, including for European companies," said Slack, co-founder of Lauxera. "We build syndicates with US specialist investors that share our ambition to create category champions, enhancing the ability of our companies to access both private funding and the public markets."

In addition to the Lauxera Growth I fund dedicated to private equity, in November 2020, Lauxera Capital Partners launched a listed healthcare growth fund in partnership with Meeschaert Asset Management, called MAM Lauxera Healthcare Growth.

Investors
Lauxera Growth I's LP base is composed of international institutional investors, strategic investors and family offices, including Covea, Téthys, Compagnie Nationale à Portefeuille, Financière Dassault, Candriam (New York Life).

BPI France also invested in the vehicle, both from its balance sheet and via its growth fund-of-funds (on behalf of private insurers and the Caisse des Dépôts).

Investments
Lauxera Growth I targets growth and buyout transactions across the healthtech industry, searching for companies able to drive commercial excellence for scientific and technological innovations.

"Lauxera Growth I brings the experience, know-how, and capital necessary for the international development of companies and technologies that are capable of transforming our healthcare systems, while creating sustainable economic, societal and medical value," said Moustial.

The fund focuses on financing and accelerating the commercial growth of promising healthtech companies based in France and the rest of Europe.

Lauxera Growth I's first investment will be in a German-American hospital software-as-a-service business, which will be completed before the end of January.

People
Lauxera Capital Partners – Pierre Moustial, Samuel Levy, Alex Slack (founding partners).